ASIA-PACIFIC VIRAL VECTOR VACCINES MANUFACTURING MARKET FORECAST 2019-2027

ASIA-PACIFIC VIRAL VECTOR VACCINES MANUFACTURING MARKET FORECAST 2019-2027

  • October 2018 •
  • Report ID: 5591507 •
  • Format: PDF
KEY FINDINGS
The Asia Pacific regional market for viral vector vaccine manufacturing will have an estimated CAGR of 18.01% during the forecast period of 2019-2027. The Asia-Pacific viral vector vaccine manufacturing market includes countries such as China, India, Japan, Australia, South Korea and Rest of Asia-Pacific.

MARKET INSIGHTS
The key drivers for the Asia-Pacific viral vector vaccine manufacturing market are government approvals to conduct trials related to the viral vector vaccines and the rising prevalence of avian influenza in humans.The development of viral vector vaccines would assist in the treatment of avian influenza among the humans, thereby contributing to the growth of the viral vector vaccine manufacturing market in the Asia-Pacific region.

The need for viral vectors may arise for the development of new and advanced vaccines to eliminate infectious and chronic diseases, which will positively influence the growth of the viral vector vaccines manufacturing market in this country.

COMPETITIVE INSIGHTS
Prominent market players in the Asia-Pacific regional market for manufacturing viral vector vaccines are Applied Viromics, Batavia Biosciences, Benitec Biopharma, Biogen Idec (Now Biogen Inc.), Biovian, Brammer Bio, Boehringer Ingelheim Gmbh, Cell And Gene Therapy Catapult, Ceva Corporate, Cobra Biologics (Subsidiary Of Recip Ab), Ge Healthcare, Janssen Pharmaceutical Inc., Id Pharma Co. Ltd.,etc.

Companies mentioned
1. ADVANCED BIOTHERAPEUTICS CONSULTING
2. ADVANCED BIOSCIENCE LABORATORIES INC.
3. APPLIED VIROMICS
4. BATAVIA BIOSCIENCES
5. BENITEC BIOPHARMA
6. BIOGEN IDEC (NOW BIOGEN INC.)
7. BIOVIAN
8. BRAMMER BIO
9. BOEHRINGER INGELHEIM GMBH
10. CELL AND GENE THERAPY CATAPULT
11. CEVA CORPORATE
12. COBRA BIOLOGICS (SUBSIDIARY OF RECIP AB)
13. GE HEALTHCARE
14. JANSSEN PHARMACEUTICAL INC.
15. ID PHARMA CO. LTD.